MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Abstract 5505: MyD88-dependent signaling decreases the anti-tumor efficacy of epidermal growth factor receptor inhibition in head and neck cancer cells

10.1158/1538-7445.am2015-5505 ◽

2015 ◽

Author(s):

Andrean L. Simons-Burnett ◽

Adam T. Koch ◽

Laurie Love-Homan ◽

Aditya Stanam

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions

Journal of Clinical Oncology ◽

10.1200/jco.2007.10.9017 ◽

2007 ◽

Vol 25 (16) ◽

pp. 2152-2155 ◽

Cited By ~ 23

Author(s):

Arlene A. Forastiere ◽

Barbara A. Burtness

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Abstract 1829: PRAS40 as a mediator of insulin-like growth factor-1 receptor-induced resistance to epidermal growth factor receptor inhibition in head and neck cancer

10.1158/1538-7445.am2018-1829 ◽

2018 ◽

Author(s):

Michael I. Dougherty ◽

Christine E. Lehman ◽

Rolando E. Mendez ◽

Linnea E. Taniguchi ◽

Julie Wulfkuhle ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Induced Resistance ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Molecular Cancer Research ◽

10.1158/1541-7786.mcr-19-0592 ◽

2020 ◽

Vol 18 (9) ◽

pp. 1392-1401

Author(s):

Michael I. Dougherty ◽

Christine E. Lehman ◽

Adam Spencer ◽

Rolando E. Mendez ◽

Abel P. David ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Induced Resistance ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7

PLoS ONE ◽

10.1371/journal.pone.0047067 ◽

2012 ◽

Vol 7 (10) ◽

pp. e47067 ◽

Cited By ~ 51

Author(s):

Felicity C. Kalinowski ◽

Keith M. Giles ◽

Patrick A. Candy ◽

Alishum Ali ◽

Clarissa Ganda ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer

Seminars in Oncology ◽

10.1053/sonc.2002.35644 ◽

2002 ◽

Vol 29 (5 Suppl 14) ◽

pp. 18-30 ◽

Cited By ~ 58

Author(s):

Roy S. Herbst ◽

Waun Ki Hong

Keyword(s):

Monoclonal Antibody ◽

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody

Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-13-0170 ◽

2013 ◽

Vol 12 (11) ◽

pp. 2541-2558 ◽

Cited By ~ 94

Author(s):

Keith M. Giles ◽

Felicity C. Kalinowski ◽

Patrick A. Candy ◽

Michael R. Epis ◽

Priscilla M. Zhang ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Cancer Cells ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Inhibitor

Epidermal Growth Factor Receptor-Targeted Therapy for Head and Neck Cancer

Otolaryngologic Clinics of North America ◽

10.1016/j.otc.2021.04.005 ◽

2021 ◽

Author(s):

Sumita Trivedi ◽

Robert L. Ferris

Keyword(s):

Head And Neck Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?

Journal of Clinical Oncology ◽

10.1200/jco.19.01981 ◽

2019 ◽

Vol 37 (31) ◽

pp. 2807-2814 ◽

Cited By ~ 2

Author(s):

Michael J. Jelinek ◽

Everett E. Vokes

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Receptor Blockade ◽

Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0678 ◽

2007 ◽

Vol 6 (4) ◽

pp. 1414-1424 ◽

Cited By ~ 55

Author(s):

Qing Zhang ◽

Neil E. Bhola ◽

Vivian Wai Yan Lui ◽

Doris R. Siwak ◽

Sufi M. Thomas ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Neck Cancer ◽

Growth Factor Receptor ◽

Peptide Receptor ◽

Gastrin Releasing Peptide ◽